# Blue Earth Diagnostics (Bracco)

Source: https://nuclide.cc/companies/blue-earth-diagnostics/  
Nuclide record `blue-earth-diagnostics` (Company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

Blue Earth Diagnostics makes Posluma (18F-rhPSMA-7.3) and Axumin (fluciclovine) PET agents for prostate cancer.

## Summary

Blue Earth Diagnostics, based in Oxford and a subsidiary of Bracco, makes the PET imaging agents Posluma, or flotufolastat F-18, also written 18F-rhPSMA-7.3, and Axumin, or fluciclovine F-18, for prostate cancer. Posluma was approved in 2023 on the LIGHTHOUSE and SPOTLIGHT trials, and a therapeutic rhPSMA analogue is in development, which would extend the radiohybrid platform from imaging into treatment. Nuclide links it to prostate cancer and to both tracer records. Whether a fluorine-18 PSMA agent with a matched therapeutic can win share from the gallium-68 tracers already established is the open question. Flotufolastat and fluciclovine have their own pages.

## Fields

- Kind: Company
- Last checked: 2026-09-06
- HQ: Oxford
- Type: radiopharma
- Website: https://www.blueearthdiagnostics.com

## Sources

- Official website: https://www.blueearthdiagnostics.com

## Connected records

- isotopes: [Fluorine-18](https://nuclide.cc/isotopes/f-18/), [Gallium-68](https://nuclide.cc/isotopes/ga-68/)
- indications: [Prostate cancer](https://nuclide.cc/indications/prostate/)
- drugs: [Flotufolastat F-18](https://nuclide.cc/drugs/flotufolastat/), [Fluciclovine F-18](https://nuclide.cc/drugs/fluciclovine-f18/)
- trials: [[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications](https://nuclide.cc/trials/nct07432633/), [[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications](https://nuclide.cc/trials/nct07702292/), [FALCON](https://nuclide.cc/trials/falcon/), [LIGHTHOUSE](https://nuclide.cc/trials/lighthouse/), [SPOTLIGHT](https://nuclide.cc/trials/spotlight/)
- companies: [Bracco Imaging](https://nuclide.cc/companies/bracco/)
- fronts: [Molecular imaging](https://nuclide.cc/fronts/f-molecular-imaging/)

---
JSON: https://nuclide.cc/api/v1/entities/blue-earth-diagnostics.json